Overture Life and Tekservis Partner, Deploying Automated Egg and Embryo Freezing Across Turkey's Fertility Clinics
DaVitri's automated vitrification platform removes operator-dependent variation from egg and embryo freezing, giving women consistent outcomes regardless of which clinic they walk into.
Overture Life, a leading developer of automated IVF technologies and the first company to achieve live births from both robotic fertilization and robotic egg freezing, today announced a nationwide commercial partnership with Tekservis to deploy its DaVitri automated egg and embryo freezing platform across fertility clinics in Turkey. The rollout marks one of the first large-scale implementations of IVF automation at a national level and provides immediate access to standardized vitrification technology, positioning Turkey as an early proving ground for a model of care built on reproducibility and throughput.
The expansion comes as IVF enters a period of structural change. For decades, outcomes have depended on highly trained embryologists performing technically sensitive procedures by hand, a model that has enabled millions of births but introduced variability across clinics and limited how quickly high-quality care can scale. As patient demand increases with delayed family planning and broader adoption of fertility preservation, those constraints are becoming more pronounced.
